Literature DB >> 6770754

Sulfamethoxazole-trimethoprim synergism for Neisseria gonorrhoeae.

M F Rein, W C Elliott, J M Swenson, C Thornsberry.   

Abstract

Sulfamethoxazole and trimethoprim are synergistic against many bacteria in sulfamethoxazole/trimethoprim concentrations of 20:1, but single-dose therapy of gonorrhea with the combination is disappointing. We used agar dilution techniques to determine minimal inhibitory concentrations of sulfamethoxazole and trimethoprim for 168 gonococci isolated from men with acute urethritis in Atlanta, Ga. The geometric mean minimal inhibitory concentrations were 5.6 microgram of sulfamethoxazole per ml and 24.3 microgram of trimethoprim per ml, a ratio of 1:4. The concentration of sulfamethoxazole inhibiting 50% of gonococcal strains dropped only from 4.7 microgram/ml to 2.9 microgram/ml with the addition of a 1/20 dilution of trimethoprim. We studied synergism with various ratios of sulfamethoxazole to trimethoprim against 20 random strains. A ratio of 1:1 was always synergistic and was the most synergistic ratio for 15 strains, whereas the 19:1 ratio was never the most syngergistic. The 19:1 ratio failed to show synergism against seven strains, but showed antagonism at this ratio with five of these seven. The sulfamethoxazole/trimethoprim ratio of 19:1 usually achieved in serum after oral administration is minimally syngergistic and is sometimes antagonistic for gonococci.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6770754      PMCID: PMC283765          DOI: 10.1128/AAC.17.2.247

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  15 in total

1.  Single-dose treatment of gonorrhoea with cotrimoxazole. A report on 1,223 cases.

Authors:  G Rahim
Journal:  Br J Vener Dis       Date:  1975-06

2.  Treatment of gonorrhoea with trimethoprim-sulphamethoxazole and probenecid plus procaine penicillin in Rwanda.

Authors:  A Z Meheus; E Ngamije; P Freyens
Journal:  Br J Vener Dis       Date:  1974-12

3.  In-vitro activity of twelve antibacterial agents against Neisseria gonorrhoeae.

Authors:  I Phillips; M Ridley; D Rimmer; R Lynn
Journal:  Lancet       Date:  1970-02-07       Impact factor: 79.321

4.  Pharmacokinetics of the antibacterial combination sulfamethoxazole plus trimethoprim in patients with normal or impaired kidney function.

Authors:  J Rieder; D E Schwartz; M Fernex; T Bergan; E K Brodwall; A Blumberg; P Cottier; W Scheitlin
Journal:  Antibiot Chemother (1971)       Date:  1974

5.  Pharmacokinetic studies of co-trimoxazole in man after single and repeated doses.

Authors:  P Kremers; J Duvivier; C Heusghem
Journal:  J Clin Pharmacol       Date:  1974 Feb-Mar       Impact factor: 3.126

6.  Comparison of methods for assessing in vitro antibiotic synergism against Pseudomonas and Serratia.

Authors:  R J Weinstein; L S Young; W L Hewitt
Journal:  J Lab Clin Med       Date:  1975-11

7.  Trimethoprim-sulfamethoxazole in the treatment of gonorrhea: comparison with standard treatment schedules.

Authors:  W C Duncan; J M Knox; T H Jackson
Journal:  South Med J       Date:  1975-09       Impact factor: 0.954

8.  Concentrations of trimethoprim-sulfamethoxazole in blood after a single, large oral dose.

Authors:  T T Yoshikawa; L B Guze
Journal:  Antimicrob Agents Chemother       Date:  1976-09       Impact factor: 5.191

9.  Potentiation of sulphamethoxazole by trimethoprim in Neisseria gonorrhoeae strains.

Authors:  E Stolz; M F Michel; H G Zwart
Journal:  Chemotherapy       Date:  1977       Impact factor: 2.544

10.  Novel method for detection of beta-lactamases by using a chromogenic cephalosporin substrate.

Authors:  C H O'Callaghan; A Morris; S M Kirby; A H Shingler
Journal:  Antimicrob Agents Chemother       Date:  1972-04       Impact factor: 5.191

View more
  3 in total

1.  Influence of inoculum size on comparative susceptibilities of penicillinase-positive and -negative Neisseria gonorrhoeae to 31 antimicrobial agents.

Authors:  W H Hall; B J Opfer
Journal:  Antimicrob Agents Chemother       Date:  1984-08       Impact factor: 5.191

2.  Clinical pharmacokinetics of co-trimoxazole (trimethoprim-sulphamethoxazole).

Authors:  R B Patel; P G Welling
Journal:  Clin Pharmacokinet       Date:  1980 Sep-Oct       Impact factor: 6.447

Review 3.  Co-trimoxazole (trimethoprim-sulfamethoxazole): an updated review of its antibacterial activity and clinical efficacy.

Authors:  G P Wormser; G T Keusch; R C Heel
Journal:  Drugs       Date:  1982-12       Impact factor: 9.546

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.